Logo image of BKD

BROOKDALE SENIOR LIVING INC (BKD) Stock Fundamental Analysis

NYSE:BKD - New York Stock Exchange, Inc. - US1124631045 - Common Stock - Currency: USD

7.725  -0.01 (-0.06%)

Fundamental Rating

2

Taking everything into account, BKD scores 2 out of 10 in our fundamental rating. BKD was compared to 103 industry peers in the Health Care Providers & Services industry. BKD has a bad profitability rating. Also its financial health evaluation is rather negative. BKD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year BKD has reported negative net income.
In the past year BKD had a positive cash flow from operations.
BKD had negative earnings in 4 of the past 5 years.
BKD had a positive operating cash flow in 4 of the past 5 years.
BKD Yearly Net Income VS EBIT VS OCF VS FCFBKD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

With a Return On Assets value of -3.82%, BKD is not doing good in the industry: 64.08% of the companies in the same industry are doing better.
BKD has a Return On Equity of -161.77%. This is in the lower half of the industry: BKD underperforms 77.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.92%, BKD is in line with its industry, outperforming 41.75% of the companies in the same industry.
Industry RankSector Rank
ROA -3.82%
ROE -161.77%
ROIC 0.92%
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
BKD Yearly ROA, ROE, ROICBKD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60 -80

1.3 Margins

BKD's Operating Margin of 2.07% is in line compared to the rest of the industry. BKD outperforms 47.57% of its industry peers.
In the last couple of years the Operating Margin of BKD has grown nicely.
Looking at the Gross Margin, with a value of 25.92%, BKD is in line with its industry, outperforming 51.46% of the companies in the same industry.
BKD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 2.07%
PM (TTM) N/A
GM 25.92%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
BKD Yearly Profit, Operating, Gross MarginsBKD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

More info and screens

0

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BKD is destroying value.
Compared to 1 year ago, BKD has more shares outstanding
BKD has more shares outstanding than it did 5 years ago.
BKD has a better debt/assets ratio than last year.
BKD Yearly Shares OutstandingBKD Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
BKD Yearly Total Debt VS Total AssetsBKD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of -0.22, we must say that BKD is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -0.22, BKD is not doing good in the industry: 79.61% of the companies in the same industry are doing better.
A Debt/Equity ratio of 29.13 is on the high side and indicates that BKD has dependencies on debt financing.
The Debt to Equity ratio of BKD (29.13) is worse than 86.41% of its industry peers.
Industry RankSector Rank
Debt/Equity 29.13
Debt/FCF N/A
Altman-Z -0.22
ROIC/WACC0.11
WACC8.09%
BKD Yearly LT Debt VS Equity VS FCFBKD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 0.82 indicates that BKD may have some problems paying its short term obligations.
BKD's Current ratio of 0.82 is on the low side compared to the rest of the industry. BKD is outperformed by 79.61% of its industry peers.
BKD has a Quick Ratio of 0.82. This is a bad value and indicates that BKD is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.82, BKD is not doing good in the industry: 72.82% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
BKD Yearly Current Assets VS Current LiabilitesBKD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

More info and screens

3

3. Growth

3.1 Past

BKD shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -35.06%.
Looking at the last year, BKD shows a small growth in Revenue. The Revenue has grown by 3.65% in the last year.
The Revenue has been decreasing by -5.08% on average over the past years.
EPS 1Y (TTM)-35.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
Revenue 1Y (TTM)3.65%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.96%

3.2 Future

BKD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 17.30% yearly.
BKD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.26% yearly.
EPS Next Y16.78%
EPS Next 2Y20.4%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue Next Year2.37%
Revenue Next 2Y-0.64%
Revenue Next 3Y1.26%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BKD Yearly Revenue VS EstimatesBKD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
BKD Yearly EPS VS EstimatesBKD Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

BKD reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BKD is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BKD Price Earnings VS Forward Price EarningsBKD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BKD is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.46
BKD Per share dataBKD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

BKD's earnings are expected to grow with 17.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.4%
EPS Next 3Y17.3%

More info and screens

0

5. Dividend

5.1 Amount

BKD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BROOKDALE SENIOR LIVING INC

NYSE:BKD (8/5/2025, 10:35:05 AM)

7.725

-0.01 (-0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-06 2025-08-06/amc
Inst Owners99.94%
Inst Owner Change0.18%
Ins Owners0.8%
Ins Owner Change0.06%
Market Cap1.81B
Analysts72
Price Target7.4 (-4.21%)
Short Float %4.74%
Short Ratio3.76
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-109.89%
Min EPS beat(2)-145.33%
Max EPS beat(2)-74.45%
EPS beat(4)0
Avg EPS beat(4)-64.42%
Min EPS beat(4)-145.33%
Max EPS beat(4)-12.21%
EPS beat(8)2
Avg EPS beat(8)-28.12%
EPS beat(12)4
Avg EPS beat(12)-12.37%
EPS beat(16)7
Avg EPS beat(16)8.7%
Revenue beat(2)0
Avg Revenue beat(2)-1.23%
Min Revenue beat(2)-1.36%
Max Revenue beat(2)-1.1%
Revenue beat(4)0
Avg Revenue beat(4)-1.16%
Min Revenue beat(4)-1.36%
Max Revenue beat(4)-1%
Revenue beat(8)0
Avg Revenue beat(8)-0.94%
Revenue beat(12)0
Avg Revenue beat(12)-0.82%
Revenue beat(16)0
Avg Revenue beat(16)-1.14%
PT rev (1m)0%
PT rev (3m)3.57%
EPS NQ rev (1m)3.53%
EPS NQ rev (3m)-3.41%
EPS NY rev (1m)-2.56%
EPS NY rev (3m)-30.95%
Revenue NQ rev (1m)0.17%
Revenue NQ rev (3m)0.3%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.57
P/FCF N/A
P/OCF 9.49
P/B 12.34
P/tB 15.16
EV/EBITDA 13.46
EPS(TTM)-1.04
EYN/A
EPS(NY)-0.49
Fwd EYN/A
FCF(TTM)-1.82
FCFYN/A
OCF(TTM)0.81
OCFY10.54%
SpS13.47
BVpS0.63
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.82%
ROE -161.77%
ROCE 1.16%
ROIC 0.92%
ROICexc 0.96%
ROICexgc 0.96%
OM 2.07%
PM (TTM) N/A
GM 25.92%
FCFM N/A
ROA(3y)-3.53%
ROA(5y)-2.19%
ROE(3y)-60.92%
ROE(5y)-37.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y47.69%
ROICexc growth 3YN/A
ROICexc growth 5Y48.52%
OM growth 3YN/A
OM growth 5Y54.21%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.08%
GM growth 5Y3.43%
F-Score4
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 29.13
Debt/FCF N/A
Debt/EBITDA 9.73
Cap/Depr 165.39%
Cap/Sales 19.58%
Interest Coverage 0.27
Cash Conversion 43.42%
Profit Quality N/A
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z -0.22
F-Score4
WACC8.09%
ROIC/WACC0.11
Cap/Depr(3y)69.44%
Cap/Depr(5y)87.89%
Cap/Sales(3y)8.28%
Cap/Sales(5y)9.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-35.06%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-115.38%
EPS Next Y16.78%
EPS Next 2Y20.4%
EPS Next 3Y17.3%
EPS Next 5YN/A
Revenue 1Y (TTM)3.65%
Revenue growth 3Y4.25%
Revenue growth 5Y-5.08%
Sales Q2Q%3.96%
Revenue Next Year2.37%
Revenue Next 2Y-0.64%
Revenue Next 3Y1.26%
Revenue Next 5YN/A
EBIT growth 1Y82.52%
EBIT growth 3YN/A
EBIT growth 5Y46.37%
EBIT Next Year528.24%
EBIT Next 3Y95.37%
EBIT Next 5YN/A
FCF growth 1Y-163.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y276.93%
OCF growth 3YN/A
OCF growth 5Y-5.14%